| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a61f9dce5bb8f46b1422f97f4428273d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0601
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-0208
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5152
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-062 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3683
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3681
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-17 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-06 |
| filingDate |
2004-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2010-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d81276999611a9b5d9828c0169225695 |
| publicationDate |
2010-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7666426-B2 |
| titleOfInvention |
Method for immune response eliciting in a mammal |
| abstract |
The invention relates to immunology, in particular to methods for influencing the immune system, and may be useful in immunotherapy for diseases of humans and animals, including therapy for oncological, autoimmune, and viral diseases. The invention comprises exposure of tumor cells obtained ex vivo or pathological cells of a non-tumorous nature or of a fraction of a biological fluid of a mammal containing viruses or bacteria to radiation of the optical range in the presence or absence of photochemical agents or treatment of said cells, viruses, or bacteria by other physical factors or chemical substances known in the art. The cells of suspensions containing viruses or bacteria are administered into the lymphatic system of said mammal. Treated cells or suspensions obtained from an exogenous source and possessing their biologically activity before the treatment may also be administered endolymphatically. The method of the invention enhances the efficacy and usability of immunotherapy. |
| priorityDate |
2004-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |